Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02830165
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
Jonsson Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT01409200
What this trial is testing

Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis

Who this might be right for
Metastatic Malignant Neoplasm in Lymph NodeProstate Ductal AdenocarcinomaStage III Prostate Adenocarcinoma AJCC v7+1 more
M.D. Anderson Cancer Center 73
Early research (Phase 1)Study completedNCT00305747
What this trial is testing

Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 12
Not applicableUnknownNCT01177865
What this trial is testing

Study of Treatment Choice in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 432
Early research (Phase 1)Study completedNCT00099086
What this trial is testing

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 20
Testing effectiveness (Phase 2)Ended earlyNCT01126879
What this trial is testing

Genistein in Treating Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Northwestern University 12
Early research (Phase 1)Study completedNCT01028885
What this trial is testing

MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+2 more
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Study completedNCT04037254
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+4 more
NRG Oncology 22
Large-scale testing (Phase 3)Looking for participantsNCT07426055
What this trial is testing

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate BrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Testing effectiveness (Phase 2)Study completedNCT01075308
What this trial is testing

SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 32
Early research (Phase 1)Study completedNCT02603965
What this trial is testing

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25
Large-scale testing (Phase 3)Study completedNCT03274687
What this trial is testing

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7+1 more
NRG Oncology 296
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT00002651
What this trial is testing

SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 3,040
Early research (Phase 1)Active Not RecruitingNCT01480154
What this trial is testing

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmStage III Cutaneous Melanoma AJCC v7Stage III Prostate Cancer AJCC v7+7 more
National Cancer Institute (NCI) 62
Large-scale testing (Phase 3)Active Not RecruitingNCT01444820
What this trial is testing

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 329
Testing effectiveness (Phase 2)WithdrawnNCT00771017
What this trial is testing

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00002723
What this trial is testing

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 390
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT01882985
What this trial is testing

Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
University of California, Irvine 14
Next Page